Every Form 4 that Viavi Solutions Inc. (VIAV) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow VIAV and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full VIAV filings page.
VIAVI Solutions (VIAV) director reported a grant of 14,369 restricted stock units (RSUs) on 11/13/2025, according to a Form 4 filing. The units vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. Following the transaction, 14,369 derivative securities were beneficially owned, with ownership reported as direct.
Viavi Solutions (VIAV) director reported an equity award of 14,369 restricted stock units (RSUs) on 11/13/2025. Each RSU is tied to one share of common stock.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes there are no expiration dates on RSUs.
Following the reported transaction, the director’s beneficially owned derivative securities total 14,369, held directly.
Viavi Solutions (VIAV) filed a Form 4 reporting a director’s grant of 14,369 restricted stock units (RSUs) on 11/13/2025 at a price of $0. Following the grant, the director beneficially owns 14,369 shares directly.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The RSUs have no expiration date.
Viavi Solutions (VIAV) disclosed a Form 4 showing a company director received 14,369 restricted stock units (RSUs) on November 13, 2025 at a price of $0.
The RSUs will vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders, and RSUs have no expiration date. Following the transaction, 14,369 derivative securities are beneficially owned, reported as direct ownership. Each RSU represents a right to receive one share of common stock upon vesting.
Viavi Solutions (VIAV) reported an insider equity award. A director received 14,369 restricted stock units (RSUs) on 11/13/2025 at a stated price of $0. The RSUs are scheduled to vest on the earlier of the one-year anniversary of grant or the next Annual Meeting of Stockholders. Following the transaction, the reporting person beneficially owned 14,369 derivative securities, held directly. RSUs have no expiration date.
Viavi Solutions (VIAV) reported an insider equity award on Form 4. A director acquired 14,369 restricted stock units (RSUs) on 11/13/2025 at a reported price of $0.
The RSUs cover 14,369 shares of common stock and will vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes there are no expiration dates on RSUs. The position is reported as direct ownership.
Viavi Solutions (VIAV) disclosed a director equity grant on Form 4. On 11/13/2025, the reporting person received 14,369 restricted stock units (transaction code A) at $0. The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders, and RSUs carry no expiration. After the transaction, 14,369 derivative securities were beneficially owned directly.
Viavi Solutions (VIAV) insider activity: A company director reported two open-market sales of common stock on 11/10/2025. The transactions included 23,529 shares sold at a weighted average price of $18.22 and 97,938 shares sold at a weighted average price of $18.17. Following these sales, the reporting person directly beneficially owned 27,213 shares. The filing notes that trades were executed in multiple transactions within the stated price ranges, and full trade details are available upon request.
Viavi Solutions (VIAV) reported an insider equity change by a director. On November 7, 2025, restricted stock units vested and converted into 23,529 shares of common stock at $0 per share (transaction code M). Following the settlement, the director directly holds 142,497 shares.
The RSUs convert one-for-one into common stock and vested 100% on November 7, 2025; the reported RSU balance from this grant is now 0. The filing does not show any share sales.
Viavi Solutions (VIAV) reported an insider equity event. A director settled restricted stock units, converting them into 23,529 shares of common stock on November 7, 2025 at a stated price of $0 per the award terms. Following the transaction, the director beneficially owns 75,924 shares directly. The RSU award vested 100% on November 7, 2025, and RSUs carry no expiration, per the footnotes.
Viavi Solutions Inc. (VIAV) reported a director’s RSU vesting and conversion to common stock. On 11/07/2025, 23,529 restricted stock units converted into an equal number of common shares at $0 under transaction code M. Following this event, the reporting person directly owned 203,862 shares. The RSUs vested 100% on November 7, 2025, and RSUs have no expiration date.
Viavi Solutions (VIAV) reported an insider equity change. A director acquired 23,529 shares of common stock on November 7, 2025 through the conversion of restricted stock units (Transaction Code M) at $0. Following this settlement, the director beneficially owns 65,766 shares, held directly.
The RSUs converted on a 1-for-1 basis and vested 100% on November 7, 2025. The filing shows 0 derivative securities remaining after the transaction.
VIAVI Solutions (VIAV) reported an insider equity change. On 11/07/2025, a Director settled Restricted Stock Units (RSUs) into common stock under transaction code M, receiving 6,768 shares at $0.
Following the settlement, the insider beneficially owned 6,768 shares directly, and the RSU derivative position shown in the filing moved to 0. Per the award terms, each stock unit converts into one share upon vesting; units vest on the earlier of the one-year grant anniversary or the next Annual Meeting of Stockholders.
Viavi Solutions (VIAV) filed a Form 4 disclosing an insider equity change. A director acquired 23,529 shares of common stock at $0 on November 7, 2025, coded “M,” reflecting the conversion of restricted stock units. Following the transaction, the director beneficially owns 172,053 shares in direct ownership. Each stock unit converts into one share upon vesting, and these units vested 100% on November 7, 2025; RSUs carry no expiration date.
VIAVI Solutions (VIAV) Form 4: A company director reported the vesting and settlement of restricted stock units into 6,768 shares of common stock on 11/07/2025. The transaction was coded “M,” indicating a conversion of derivatives, with the shares acquired at $0 per share. Following the transaction, the director beneficially owns 6,768 common shares directly, and holds 0 RSUs. The RSUs convert 1-for-1 into common stock and vest on the earlier of the one-year grant anniversary or the next annual meeting.
VIAVI Solutions (VIAV) disclosed a director’s RSU vesting and settlement. On November 7, 2025, 23,529 restricted stock units converted into an equal number of common shares at $0 per share (code M). No shares were sold in this filing.
Following the transaction, the reporting person directly owns 240,683 common shares. The RSUs vested 100% on November 7, 2025 and, per the disclosure, RSUs have no expiration date.
VIAVI Solutions (VIAV) reported a director transaction on Form 4 tied to an RSU vesting on November 7, 2025. The filing shows 23,529 shares of common stock acquired at $0 under code “M” (conversion of RSUs). After this transaction, the director beneficially owns 148,680 shares, held directly. Each stock unit converted 1-for-1 into common stock, and the RSU award had no expiration, with units vesting 100% on November 7, 2025.
Viavi Solutions (VIAV) reported a Form 4 showing a company director sold common stock in two transactions on 11/04/2025. The director sold 23,050 shares at a weighted average price of $16.98 and 16,950 shares at $17.24, and held 148,524 shares directly after the reported sales.
The first sale was executed in multiple trades within a price range of $16.97–$17.03, with the reported price reflecting the weighted average. The filing states the reporting person will provide full trade detail upon request.
VIAVI Solutions Inc. (VIAV) reported an insider transaction on a Form 4. An officer (SVP General Manager OSP) sold 9,765 shares of common stock on 11/03/2025 at $17.45 per share. Following the sale, the officer directly beneficially owned 61,820 shares. The filing notes that the balance reflects an administrative adjustment.
VIAVI Solutions (VIAV) reported an insider transaction by its EVP, Chief Marketing & Strategy Officer. On 11/03/2025, the officer sold 12,617 shares of common stock at a weighted average price of $17.41, executed in multiple trades ranging from $17.40 to $17.43. Following the sale, the reporting person beneficially owns 28,044 shares. The filing notes the balance reflects an administrative adjustment.
Viavi Solutions (VIAV): Director insider sale disclosed. On 11/03/2025, a director sold 40,363 shares of common stock at $17.25 and 13,570 shares at $17.34. Following these transactions, the reporting person beneficially owns 125,151 shares, held directly. A footnote states the balance reflects an administrative adjustment.
Viavi Solutions (VIAV): An officer reported an open-market sale. The SVP, General Counsel & Secretary sold 11,148 shares of common stock on 11/03/2025 at a weighted average price of $17.29, with individual trades executed between $17.29 and $17.32.
Following the transaction, the reporting person beneficially owns 73,450 shares, held directly. The filing notes availability of full trade detail upon request.
VIAVI Solutions Inc. reporting person Paul McNab, EVP, Chief Marketing & Strategy Officer, filed a Form 4 disclosing an insider disposition of common stock on 10/01/2025. The filing reports a disposition of 5,509 shares under transaction code G(1) as an exempt transfer at no cash price, leaving 63,265 shares beneficially owned following the transaction. The Form 4 is signed by an attorney-in-fact on 10/08/2025. The filing indicates the report was made by one reporting person and identifies the filer as both an officer and director.